ISEE
Income statement / Annual
Last year (2022), IVERIC bio, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, IVERIC bio, Inc.'s net income was -$175.75 M.
See IVERIC bio, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$209.98 M
|
$50.91 M
|
$51.51 M
|
$41.26 M
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$209.98 M |
$50.91 M |
$51.51 M |
$41.26 M |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
0 |
| Research and Development
Expenses |
$117.01 M
|
$85.07 M
|
$62.78 M
|
$39.64 M
|
$41.74 M
|
$66.29 M
|
$196.30 M
|
$131.01 M
|
$88.39 M
|
$33.22 M
|
| General & Administrative
Expenses |
$72.89 M
|
$29.69 M
|
$25.95 M
|
$21.63 M
|
$23.61 M
|
$35.68 M
|
$50.18 M
|
$44.02 M
|
$33.39 M
|
$14.21 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$72.89 M
|
$29.69 M
|
$25.95 M
|
$21.63 M
|
$23.61 M
|
$35.68 M
|
$50.18 M
|
$44.02 M
|
$33.39 M
|
$14.21 M
|
| Other Expenses |
$62,000.00 |
-$10,000.00 |
-$6,000.00 |
$151,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$189.91 M |
$114.76 M |
$88.74 M |
$61.27 M |
$65.35 M |
$101.97 M |
$246.47 M |
$175.03 M |
$121.77 M |
$47.43 M |
| Cost And Expenses |
$189.91 M |
$114.76 M |
$88.74 M |
$61.27 M |
$65.35 M |
$101.97 M |
$246.47 M |
$175.03 M |
$121.77 M |
$47.43 M |
| Interest Income |
$2.26 M |
$245,000.00 |
$500,000.00 |
$2.15 M |
$2.39 M |
$1.52 M |
$1.70 M |
$971,000.00 |
$217,000.00 |
-$1.45 M |
| Interest Expense |
$2.26 M |
$0.00 |
$500,000.00 |
$2.15 M |
$2.39 M |
$1.52 M |
$1.70 M |
$971,000.00 |
$217,000.00 |
$1.45 M |
| Depreciation &
Amortization |
-$2.37 M
|
$39,000.00
|
$143,000.00
|
$162,000.00
|
$183,000.00
|
$2.76 M
|
$757,000.00
|
$698,000.00
|
$127,000.00
|
$20,000.00
|
| EBITDA |
-$192.28 M
|
-$114.76 M
|
-$88.74 M
|
-$61.27 M
|
$62.21 M
|
$112.26 M
|
-$193.07 M
|
-$121.81 M
|
-$80.17 M
|
-$49.67 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0.53 |
-3.79 |
-2.36 |
-1.94 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0.51
|
-3.84
|
-2.4
|
-1.95
|
0
|
| Total Other
Income/Expenses Net |
$4.70 M
|
$235,000.00
|
$494,000.00
|
$2.30 M
|
$127.37 M
|
$1.49 M
|
$1.74 M
|
$1.02 M
|
$217,000.00
|
-$3.72 M
|
| Income Before Tax |
-$185.21 M |
-$114.52 M |
-$88.24 M |
-$58.97 M |
$62.02 M |
$109.49 M |
-$193.83 M |
-$122.50 M |
-$80.30 M |
-$51.15 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0.52
|
-3.81
|
-2.38
|
-1.95
|
0
|
| Income Tax Expense |
-$9.47 M |
-$284,000.00 |
-$3.70 M |
-$111,000.00 |
-$1.06 M |
-$4.71 M |
-$406,000.00 |
-$16.79 M |
$17.89 M |
-$2.27 M |
| Net Income |
-$175.75 M |
-$114.24 M |
-$84.55 M |
-$58.86 M |
$63.09 M |
$114.21 M |
-$193.42 M |
-$105.72 M |
-$98.19 M |
-$51.15 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0.54 |
-3.8 |
-2.05 |
-2.38 |
0 |
| EPS |
-1.45 |
-1.12 |
-1.14 |
-1.39 |
1.7 |
3.18 |
-5.45 |
-3.06 |
-2.95 |
-5.68 |
| EPS Diluted |
-1.45 |
-1.12 |
-1.14 |
-1.39 |
1.7 |
3.17 |
-5.45 |
-3.06 |
-2.95 |
-5.68 |
| Weighted Average Shares
Out |
$121.04 M
|
$101.87 M
|
$74.19 M
|
$42.22 M
|
$37.09 M
|
$35.92 M
|
$35.49 M
|
$34.58 M
|
$33.26 M
|
$9.00 M
|
| Weighted Average Shares
Out Diluted |
$121.04 M
|
$101.87 M
|
$74.19 M
|
$42.22 M
|
$37.09 M
|
$36.01 M
|
$35.49 M
|
$34.58 M
|
$33.26 M
|
$9.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
